Search PubMed⌕ Search

Biomedical subjects

M S Collins

Publications and source records attributed to M S Collins.

At least 55 records · Page 3Linked to original sources
PubMed1988

Characterization of a virus associated with turkey rhinotracheitis.

A virus associated with turkey rhinotracheitis was purified and its morphology and structural polypeptides were compared with those of the bovine, human and murine members of the genus Pneumovirus. The isolate possessed surface projections 13 to 14 nm in length and a helical nucleocapsid 14 nm in diameter with a pitch of 7 nm. Approximately seven presumed viral polypeptides were observed. Their apparent molecular weights were 200 x 10(3) (200K), 84K, 54K, 42K, 37K, 31K and 14K; two of these, the 84K and 54K polypeptides, were glycosylated. The virus was shown to possess many features that were similar to established pneumoviruses and can therefore be regarded as a possible member of this genus.

Animals↗
PubMed1987

Strain specific antibodies revealed by immunoabsorption studies with avian infectious bronchitis virus.

Rabbit antisera prepared against the Massachusetts 41 (M41) strain of avian infectious bronchitis virus (IBV) and absorbed with chick embryo immunoabsorbent produced multiple precipitin lines in immunodouble-diffusion (IDD) tests with homologous or heterologous strains of virus. These precipitin lines were all removed by absorption with concentrated M41 virus preparations, but repeated absorption with concentrated, purified preparations of IBV strains: T, Holte, Connecticut, Beaudette or H120 failed to remove all precipitin lines produced to M41 virus, although all those to the heterologous viruses were removed. The remaining line(s) produced with M41 virus by sera absorbed with different heterologous viruses showed identity in IDD tests and was associated with the surface projections of the virus.

Animals↗
PubMed1987

[Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].

Three immunoglobulin preparations for intravenous infusion were compared in vivo to determine their relative protective capacity against several gram-negative and gram-positive pathogens. Polyglobin N is a conventional IgG concentrate. Psomaglobin N is identical in formulation to Polyglobin N but is prepared from the plasma of donors who have naturally high levels of antibody to lipopolysaccharide antigens of Pseudomonas aeruginosa. IgGMA is a conventional IgG concentrate containing 12% IgG and 16% IgA. In a murine model of burn wound sepsis the three IgG preparations were similarly protective against three or ten strains of P. aeruginosa. Psomaglobin N and Polyglobin N were significantly (p less than or equal to 0.015) more protective than IgGMA against six of ten and three of ten strains of P. aeruginosa, respectively. In a murine model of Streptococcus pneumoniae type 3 pneumonia, the three Ig preparations were similarly protective. IgGMA was significantly more protective (p less than or equal to 0.025) than Psomaglobin N and Polyglobin N against Salmonella typhimurium in murine peritonitis. However, the mean protective dose (PD50) of the two later preparations was less than or equal to 20 mg/kg body weight. In models of peritonitis both Psomaglobin N and Polyglobin N were more protective than IgGMA (p less than or equal to 0.004) against Haemophilus influenzae b, Klebsiella pneumoniae, Serratia marcescens 06:H3 and group B Streptococcus types 1b and 1c. Psomaglobin N and ciprofloxacin were employed to treat established polymicrobial murine burn wound sepsis resulting from contamination of the burn site with mixtures of P. aeruginosa and Staphylococcus aureus.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1985

Arterial pH in out-of-hospital cardiac arrest: response time as a determinant of acidosis.

It is unclear why some victims of out-of-hospital cardiac arrest are severely acidotic on arrival to the emergency department (ED), whereas others have a pH within normal limits. To explain the difference among patients, the authors collected data on 119 consecutive out-of-hospital adult nontraumatic cardiac arrest victims brought to the University of Nebraska Medical Center by paramedic rescue squad between December 1982 and January 1984. Patients who experienced restoration of spontaneous circulation (ROSC) in the field had a normal pH (7.40 +/- 0.13) as compared with the pH of patients still receiving cardiopulmonary resuscitation (CPR) on arrival at the ED (7.18 +/- 0.20). A rapid paramedic response time was the best determinant of ROSC and a normal pH on arrival at the ED. Bystander CPR neither significantly increased the number of patients with ROSC in the field nor protected against the development of acidosis, but did improve the neurological outcome of survivors. The presence of acidosis in patients still receiving CPR on arrival in the ED could not be predicted on the basis of paramedic response time, amount of sodium bicarbonate given in the field, whether or not the collapse was witnessed, or whether or not bystander CPR had been performed. Patients who were acidotic had a significantly higher (P less than 0.001) Paco2 (101 +/- 33 mm Hg) and a lower Pao2 (41 +/- 69 mm Hg) than patients with a normal pH (Paco2 37 +/- 10 mm Hg, Pao2 134 +/- 107 mm Hg). Adequacy of ventilation is the principal determinant of acidosis in patients who are still receiving CPR on arrival at the ED.

Acidosis↗
PubMed1985

Efficaciousness of immunoglobulin G prophylaxis on mortality and physiological variables in gram-negative peritonitis in rodents.

A rapidly expanding role involving the use of immunoglobulin preparations in conditions other than the classical immunodeficiency syndromes is evident in recent years. Treatment with immunoglobulin may be especially important during infection in which specific antibody to pathogens has been consumed, degraded, or not produced and in cases in which antibiotic treatment is ineffective. Recent studies in animals and humans support this concept, although further studies are needed to fully develop it. This study was completed to explore possible beneficial effects of prophylactic treatment of rodents during severe Salmonella typhimurium peritonitis with a newly developed native immunoglobulin G preparation for intravenous use (IGIV pH 4.25). This study demonstrates that IGIV pH 4.25 increases survival time and decreases absolute mortality, prevents hypotension and acidosis, and ameliorates or prevents changes in variables indicative of organ damage during S. typhimurium bacteremia in the rat. Studies in mice indicate that protection is mediated by antibody to cell surface antigen (s) of S. typhimurium.

Acidosis↗
PubMed1984

Paramyxovirus type 1 infections of racing pigeons: 1 characterisation of isolated viruses.

Viruses isolated from field outbreaks of disease in racing pigeons in continental Europe and Great Britain were shown to be identical by serological tests using conventional chicken antisera and mouse monoclonal antibodies. The pigeon viruses showed high levels of cross-reaction to Newcastle disease virus (NDV) in haemagglutination inhibition tests and Madin-Darby bovine kidney cells infected with pigeon virus isolates bound three out of nine mouse monoclonal antibodies prepared against NDV Ulster 2C. These results confirm their classification in the paramyxovirus type 1 serotype of avian paramyxoviruses. However, the pigeon viruses could be distinguished from more classical paramyxovirus type 1 viruses by the significantly different titres obtained in haemagglutination inhibition tests, the failure of mouse monoclonal antibodies directed against the HN1 epitope of NDV Ulster 2C to inhibit their haemagglutinating activity and a unique binding pattern seen with the nine mouse monoclonal antibodies.

Animals↗
PubMed1984

Antibody levels in reduced/alkylated intravenous immune globulin.

Antibody titers, found in representative lots of a reduced and alkylated intravenous immune globulin, against a variety of common microorganisms are presented. With the more frequently occurring pathogens the specific antibody level does not vary significantly between lots. Depending upon the type of assay used, antibody titers per se may or may not reflect the therapeutic activity of the preparation against a specific microorganism.

Antibodies↗
PubMed1984

Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.

Immunoglobulin G intravenous is prepared by controlled reduction and alkylation of approximately four interheavy chain disulfide bonds per molecule. To determine if the protective activity of antibody modified by this process is diminished, mice were treated with identical doses of reduced and alkylated IgG and native IgG prepared from the same plasma pool. Three hours later mice were given a 10 percent body surface burn followed by challenge with the seven Fisher-Devlin-Gnabasik immunotypes of Pseudomonas aeruginosa. Against five of the seven immunotypes, the 50 percent protective doses were approximately 100 mg or less per kg body weight. Overall there was no significant difference in protection afforded to the mice by the two immunoglobulin preparations indicating that in vivo the activity of IgG against P. aeruginosa remains unimpaired by reduction and alkylation. In the second part of this study, immunoglobulin G intravenous significantly enhanced the activity of tobramycin and carbenicillin in the treatment of P. aeruginosa infection in burned mice and of penicillin G in the treatment of group B Streptococcus 1C infection in normal mice.

Animals↗
PubMed1984

Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.

Human plasmas containing naturally high levels of immunoglobulin G (IgG) to lipopolysaccharide antigens of Pseudomonas aeruginosa immunotypes 1, 2, 4, and 6 were identified by an enzyme-linked immunosorbent assay. The high titered plasmas were collected, pooled, and fractionated. Cohn fraction II IgG was prepared for intravenous infusion. The antibody titers in the hyperimmune intravenous immunoglobulin preparation were approximately fivefold higher against P. aeruginosa immunotypes 1, 2, 4, 5, and 6 and approximately twofold higher against immunotypes 3 and 7 than conventional intravenous immunoglobulin G. When tested for prophylaxis in burned mice, the protective doses 50 percent of Pseudomonas-intravenous immunoglobulin G were approximately fourfold less effective against immunotypes 1, 2, 4, and 7 and International Antigenic Typing System Serotypes (IATS), 8 (= immunotype 6) than conventional intravenous immunoglobulin G. Against immunotype 3 and 5, IATS 13, 15, and 16, both immunoglobulin preparations afforded similar levels of protection. In burned mice challenged with immunotypes 1 and 2 and not treated until 18 hours after infection, Pseudomonas-intravenous immunoglobulin G and tobramycin had synergistic activity in preventing death. Pseudomonas-intravenous immunoglobulin G also afforded significant protection to immunosuppressed mice challenged with immunotype 1. These data suggest that Pseudomonas-intravenous immunoglobulin G may be useful in prevention or treatment of P. aeruginosa infections in man.

Animals↗